Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a

Hanssa Summah1, Li-Li Tao, Ying-Gang Zhu

  • 1Department of Pulmonary Medicine, Huadong Hospital, Shanghai Medical College, Fudan University, People's Republic of China.

BMC Infectious Diseases
|October 22, 2011
PubMed
Abstract

Insights

Soluble triggering receptor expressed in myeloid cells-1 (sTREM-1) shows good accuracy in diagnosing bacterial pleural effusions. This biomarker can serve as a valuable tool to aid in the early detection of pleural infections.

Area of Science:

  • Medical Diagnostics
  • Biomarker Research
  • Infectious Diseases

Background:

  • Pleural infection is a common condition requiring prompt diagnosis and antibiotic treatment.
  • Accurate differentiation of bacterial pleural effusions from other causes is crucial for effective management.
  • Soluble triggering receptor expressed in myeloid cells-1 (sTREM-1) is a potential biomarker for bacterial pleural infections.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the diagnostic accuracy of pleural fluid sTREM-1 for bacterial infections.
  • To determine the pooled sensitivity, specificity, and likelihood ratios of sTREM-1 in diagnosing bacterial pleural effusions.

Main Methods:

  • A systematic literature search was performed on Web of Knowledge and Medline (1990-March 2011).
  • Studies reporting diagnostic accuracy data for sTREM-1 in bacterial pleural effusions were included.
  • Pooled sensitivity, specificity, and summary accuracy measures were calculated using meta-analysis techniques.

Main Results:

  • The pooled sensitivity of sTREM-1 was 78% (95% CI: 72%-83%) and specificity was 84% (95% CI: 80%-87%).
  • The area under the SROC curve was 0.92, indicating good diagnostic performance.
  • Significant heterogeneity was observed for most accuracy measures, and publication bias was suggested.

Conclusions:

  • sTREM-1 demonstrates good diagnostic accuracy and can be a useful adjunctive tool for diagnosing bacterial pleural effusions.
  • Further research is warranted to differentiate the diagnostic performance of sTREM-1 in parapneumonic effusions versus empyemas.